Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Unknown 4Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Carcinoma, Non-Small-Cell Lung 74Breast Neoplasms 70Rectal Neoplasms 51Stomach Neoplasms 45Glioblastoma 45Esophageal Neoplasms 41Colorectal Neoplasms 37Lung Neoplasms 35Brain Neoplasms 35Squamous Cell Carcinoma of Head and Neck 32Pancreatic Neoplasms 31Glioma 27Neoplasms 26Sarcoma 23Neoplasm Metastasis 23Astrocytoma 22Head and Neck Neoplasms 21Carcinoma, Hepatocellular 18Esophageal Squamous Cell Carcinoma 16Colonic Neoplasms 16Recurrence 15Ovarian Neoplasms 15Melanoma 15Gliosarcoma 15Central Nervous System Neoplasms 15Urinary Bladder Neoplasms 13Oligodendroglioma 13Uterine Cervical Neoplasms 12Adenocarcinoma Of Esophagus 12Prostatic Neoplasms 11

Interventions

Gemcitabine 112Cisplatin 76Oxaliplatin 45pembrolizumab 35Fluorouracil 32Capecitabine 31lenvatinib 26durvalumab 26Leucovorin 26Magnetic Resonance Spectroscopy 14Irinotecan 13Drug Therapy 13Nivolumab 12Biopsy 12Albumin-Bound Paclitaxel 12Specimen Handling 11Radiofrequency Ablation 11130-nm albumin-bound paclitaxel 11tislelizumab 10pemigatinib 10apatinib 10Taxes 10Radiotherapy 10Floxuridine 10Folfox protocol 9Bevacizumab 9S 1 (combination) 8Photochemotherapy 8Liver Transplantation 8Cholangiopancreatography, Endoscopic Retrograde 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Surgical Procedures, Operative × Clear all
NCT07208526 2025-10-06

A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST

Shanghai Zhongshan Hospital

Phase NA Not yet recruiting
270 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06721286 2024-12-06

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
70 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06369480 2024-04-17

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

Rigshospitalet, Denmark

Unknown
2,000 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT05672537 2023-01-05

Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
70 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT02103179 2014-04-03

VEGF ECC

First Affiliated Hospital, Sun Yat-Sen University

Unknown
20 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT01917370 2013-08-06

icc

First Affiliated Hospital, Sun Yat-Sen University

Unknown
20 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡